Effect of Survivin shRNA on c-myc and nuclear factor-κB expression in esophageal cells

FENG Ming Myire?Tuerhong DONG Juan-juan Msa?Aerken LI Xiu-mei

Acta Anatomica Sinica ›› 2019, Vol. 50 ›› Issue (1) : 72-76.

PDF(2468 KB)
Welcome to visit Acta Anatomica Sinica! Today is Chinese
PDF(2468 KB)
Acta Anatomica Sinica ›› 2019, Vol. 50 ›› Issue (1) : 72-76. DOI: 10.16098/j.issn.0529-1356.2019.01.012
Cancer Biology

 Effect of Survivin shRNA on c-myc and nuclear factor-κB expression in esophageal cells

  • FENG Ming1 Myire•Tuerhong2 DONG Juan-juan2 Msa•Aerken2 LI Xiu-mei 2*
Author information +
History +

Abstract

Objective To study the effect of Survivin shRNA interference on c-myc and NF-κB expression levels in esophageal cells ECA109. Methods Survivin shRNA interference technology was applied to liposomes transfection esophageal ECA109 cells. Half quantitative RT-PCR and Western blotting method were applied to detect genes expression of c-myc and NF-κB gene. Flow cytometry was used to detect the proliferation and apoptosis of cell lines index changes. Results 1. After Survivin shRNA transfected esophageal ECA109 cells, Survivin mRNA and protein expression obviously down-regulated, and c-myc mRNA and protein expression also down-regulated; 2. After Survivin down-regulated, NF-κB mRNA expression had no obvious change, however the phosphorylated proteins level of NF-κB was reduced, whose upstream factor nuclear factor kappa B inhibitor kinase predominate(IKK) alpha, IKK beta mRNA express was cut; 3. Esophageal cell ECA109 apoptosis increased significantly. Cells ratio increased in G2 phase but decreased in S phase. The cell cycle blocked. Conclusion Survivin is effective on adjusting c-myc gene expression on mRNA and protein level. Survivin regulates NF-κB activation by down-regulation of IKK alpha, IKK beta mRNA expression.

Key words

Survivin shRNA / c-myc / Neclear factor-κB / Nuclear factor kappa &beta / inhibitor kinase α、Nuclear factor kappa &beta / inhibitor kinaseβ / Western blotting / Flow cytometry

Cite this article

Download Citations
FENG Ming Myire?Tuerhong DONG Juan-juan Msa?Aerken LI Xiu-mei.  Effect of Survivin shRNA on c-myc and nuclear factor-κB expression in esophageal cells[J]. Acta Anatomica Sinica. 2019, 50(1): 72-76 https://doi.org/10.16098/j.issn.0529-1356.2019.01.012

References

 [1] Li XM, Guo Q, Jiang XF, et al. Expression and significance of Survivin,c-myc,NF-κB in esophageal cancer of Kazak[J]. China Journal of Modern Medicine, 2013, 23(27):62-66. (in Chinese)
李秀梅,郭琼,姜孝芳,等.新疆哈萨克族食管癌中Survivin、c-myc、NF-κB的表达及其与临床因素的相关性研究[J]. 中国现代医学杂志,2013,23(27):62-66.
 [2] Peery RC, Liu JY, Zhang JT. Targeting survivin for therapeutic discovery: past, present, and future promises[J].Drug Discov Today, 2017, 22 (10): 1466-1477.
 [3] Mathieu R, Klatte T, Margulis Ⅴ, et al. Survivin is not an independent prognostic factor for patients with upper tract urothelial carcinoma: a multi-institutional study[J]. Urol Oncol, 2015, 33(11):495.e15-22.
 [4] Santarelli A, Mascitti M, Lo Russo L, et al. Survivin-based treatment strategies for squamous cell carcinoma[J]. Int J Mol Sci, 2018, 19 (4):971-995.
 [5] Yin H, Que R, Liu C, et al. Survivin targeted drug screening platform identifies a matrine derivative WM-127 as a potential therapeutics against hepatocellular carcinoma[J]. Cancer Lett, 2018, 425:54-64.
 [6] Sun XF, Li XB, Yang GT, et al. Radix Actinidiae extractive inhibits the growth of transplanted tumor of esophagus cancer cell EC109 in nude mice[J].Acta Anatomica Sinica, 2009,40(1):32-36. (in Chinese)
孙雪飞,李希波,杨国涛,等.藤梨根提取物对食管癌细胞系EC109细胞裸鼠移植瘤的抑制作用[J].解剖学报,2009,40(1):32-36. 
 [7] Kar R, Palanichamy JK, Banerjee A,et al. Survivin siRNA increases sensitivity of primary cultures of ovarian cancer cells to paclitaxel[J]. Clin Transl Oncol, 2015, 17 (9): 737-742.
 [8] Wang H, Ye YF.Effect of survivin siRNA on biological behaviour of breast cancer MCF7 cells[J]. Asian Pac J Trop Med, 2015, 8 (3): 225-228.
 [9] Li J, Han Y, Zhou D, et al. Down regulation of Survivin gene expression affects ionizing radiation resistance of human T98 glioma cells[J]. Cell Mol Neurobiol, 2018, 38 (4): 861-868.
 [10] Tracey L, Pérez-rosado A, Artiga MJ, et al. Exp ression of the NF-kappa B targets Bcl-2 and BIRC5/Survivin characterizes small B-cell and aggressive B-cell lymphomas, respectively[J]. J Pathol, 2005, 206(2):123-134.
PDF(2468 KB)

Accesses

Citation

Detail

Sections
Recommended

/